Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients

BACKGROUND: Heart transplant (HTX) recipients are prone to develop complications after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Vaccination is often ineffective due to weaker immunogenicity. In this high‐volume single‐center study, we aimed to determine factors influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kugler, Szilvia, Vári, Dorottya Katalin, Veres, Dániel Sándor, Király, Ákos, Teszák, Tímea, Parázs, Nóra, Tarjányi, Zoltán, Drobni, Zsófia, Szakál‐Tóth, Zsófia, Prinz, Gyula, Miheller, Pál, Merkely, Béla, Sax, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652352/
https://www.ncbi.nlm.nih.gov/pubmed/38018598
http://dx.doi.org/10.1002/iid3.1086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652352/
https://www.ncbi.nlm.nih.gov/pubmed/38018598
http://dx.doi.org/10.1002/iid3.1086

Ejemplares similares